Stapley Marc
Stapley Marc, CEO, reported a transaction classified as withholding at VERACYTE, INC. involving 8782.000000 shares for an estimated $394136.16. Reported holdings after the transaction were 432073.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 02, 2026
- Filing date
- Sep 04, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
VCYT price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- withholding Code F
- Identifier
- 0001539796-26-000019 Common Stock
- Transaction date
- Sep 02, 2026 Filed Sep 04, 2026, 11:53 PM · 2d delay
- Shares
- 8,782 sh $44.88 per share
- Estimated value
- -$394k Computed from shares × price
- Holdings after
- 432,073 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-12 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tax_withholding-22 points
transaction_code = F
Tax withholding on vesting shares is mechanical.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Executive Officer
- F1
Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does…
- F2
Includes 361 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.
0 other transactions
0 recent txs